COPENHAGEN, Denmark, Dec. 1, 2025 /PRNewswire/ — Danish diabetes‑tech corporate Hedia is imposing a management alternate efficient 1 December 2025, when Rasmus Kofoed will breaking in as Leading Govt Officer (CEO). He succeeds Lars Christian Lund, who upcoming roughly 2 years within the function has made up our minds to step right down to take in a Crew CEO place in every other global corporate.

Hedia develops virtual answers that backup nation with insulin‑dependent diabetes to raised perceive and lead their remedy thru knowledge, synthetic perception and person‑pleasant app era. Based in 2016, the corporate has situated itself as a prominent Eu participant in virtual diabetes control and virtual therapeutics.

Carl Bilbo, Chairman of the Board of Hedia, commented:

“Under Lars Christian Lund’s leadership, Hedia has progressed from an ambitious start‑up to a professional scale‑up with strong regulatory and commercial development. Lars has played a central role in strengthening the organisation, securing MDR approval and building the foundation for global growth. On behalf of the board I wish to thank him for his outstanding contribution and dedication. We are equally pleased to welcome Rasmus Kofoed as our new CEO. Rasmus brings a strong strategic and commercial profile with proven experience in life science and medtech. He is the right person to lead Hedia into the next phase.”

Rasmus Kofoed brings a forged background within the era science and medtech industries. He has held senior management positions at Novo Nordisk, Abbott, Roche and Medtronic, and served as CEO of ChemoMetec, with general industrial and strategic duty – together with expansion, transformation and global enlargement. With this robust industrial revel in, he’ll think the function as CEO on 1 December 2025, with ambitions to additional reinforce Hedia’s product and marketplace platform and make bigger the corporate’s global partnerships.

“I see enormous potential in Hedia,” says Rasmus Kofoed.
“The company combines clinical insight with technology in a way that creates real value for people with diabetes. I look forward to working with the team to extend our reach, strengthen our partnerships and continue the journey to make Hedia a leading player in digital diabetes care.”

With this management transition, Hedia marks the after herbal step in its expansion proceed and reaffirms its loyalty to increasing its global footprint and industrial engagement.

Site: www.hedia.com

Photograph – https://mma.prnewswire.com/media/2833717/Rasmus_Kofoed.jpg
Brand – https://mma.prnewswire.com/media/2833716/Hedia_logo.jpg

SOURCE Hedia ApS